Pembrolizumab Plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer - Keynote-189 Trial & Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer - Keynote 024 Trial
Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Pembrolizumab Plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer - Keynote-189 Trial & Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer - Keynote 024 Trial ### Output: Pembrolizumab